A modified synthesis of the antiosteoporosis drug alfacalcidol via a key photochemical transformation of 1α-5,6-Trans-Vitamin D3

Junyuan Ding,Xianghai Guo,Zhouliangzi Zeng,Ningzhi Liu
DOI: https://doi.org/10.1055/s-0033-1339867
2013-01-01
Synlett
Abstract:Alfacalcidol (1-hydroxyvitamin D-3) is an important clinical drug for the treatment of osteoporosis. Its practical synthesis has been intensively pursued across academia. The difficulties of separating 5,6-cis and 5,6-trans isomers in the current process was avoided by photochemical transformation of the 5,6-trans isomer into the 5,6-cis isomer. Employing vitamin D-3 as a starting material, alfacalcidol was obtained by a five-step reaction sequence of esterification, cyclization, oxidation, solvolysis ring-opening, and subsequent photochemical reaction. The overall yield has been greatly improved from 17% to 31%.
What problem does this paper attempt to address?